Effects of the selective serotonin reuptake inhibitor fluoxetine on glucose metabolism: A systematic review.

Zhang, Zizhen; Du, Yang; Chen, Lizhi; Liu, Ying; Du, Biao

Zhang, Zizhen; Du, Yang; Chen, Lizhi; Liu, Ying; Du, Biao.

Afiliação

Zhang Z; School of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Du Y; Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicineï¼Shanghai 200030ï¼China.
Chen L; School of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Liu Y; School of Pharmacy, North Sichuan Medical College, Nanchong 637000, China.
Du B; Department of Pharmacy, Chongqing University Three Gorges Hospital, Chongqing 404000, China. Electronic address: 1449615818@qq.com.

Asian J Psychiatr ; 73: 103092, 2022 Jul.

Article em En | MEDLINE | ID: mdl-35430493

Assuntos

Diabetes Mellitus Tipo 2; Fluoxetina; Antidepressivos; Glicemia/metabolismo; Peso Corporal; Fluoxetina/farmacologia; Fluoxetina/uso terapêutico; Glucose; Humanos; Ensaios Clínicos Controlados Aleatórios como Assunto; Inibidores Seletivos de Recaptação de Serotonina/farmacologia; Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico

Palavras-chave

Diabetes; FBG; Fluoxetine; Glycometabolism; HbA1c; Weight

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fluoxetina / Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google